<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03315676</url>
  </required_header>
  <id_info>
    <org_study_id>PPI 2017</org_study_id>
    <nct_id>NCT03315676</nct_id>
  </id_info>
  <brief_title>Efficacy of Proton Pump Inhibitors in Gastrointestinal Erosions and/or Ulcers</brief_title>
  <official_title>RCT Using Bonopurazan or Esomeprazole in Patients With NSAIDs-induced Erosions and/or Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shinshu University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shinshu University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to collect the data of clinical efficacy and safety after the usage
      of bonoprazon and esomeprazole when the patients take NSAIDs more than 2 weeks and have
      gastrointestinal symptoms who have had gastrointestinal erosions and/or ulcers in the past.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2017</start_date>
  <completion_date type="Anticipated">September 4, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 4, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with healing of gastrointestinal erosions and/or ulcers using major forceps</measure>
    <time_frame>Change from Baseline Gastrointestinal erosions and/or ulcers at 2 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Gastrointestinal Erosions and/or Ulcers</condition>
  <arm_group>
    <arm_group_label>Oral Bonoprazan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Daily intake of Bonoprazan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral Esomeprazol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Daily intake of Esomeprazol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral Bonoprazan</intervention_name>
    <description>To examine the efficacy of oral Bonoprazan in patients with NSAIDs-induced Erosions and/or Ulcers</description>
    <arm_group_label>Oral Bonoprazan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oral Esomeprazol</intervention_name>
    <description>To examine the efficacy of oral Esomeprazol in patients with NSAIDs-induced Erosions and/or Ulcers</description>
    <arm_group_label>Oral Esomeprazol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of NSAIDs-induced gastrointestinal Erosions and/or Ulcers who want
             to take Bonoprazan or Esomeprazole

        Exclusion Criteria:

          -  Patients allergic to Bonoprazan or Esomeprazole
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Male patients are separately analyzed</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yukio Nakamura, MD, PhD</last_name>
    <phone>+81-263-37-2659</phone>
    <email>yxn14@aol.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>Yukio Nakamura</name>
      <address>
        <city>Matsumoto</city>
        <state>Nagano</state>
        <zip>3908621</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yukio Nakamura, MD, PhD</last_name>
      <phone>+81-263-37-2659</phone>
      <email>yxn14@aol.jp</email>
    </contact>
    <investigator>
      <last_name>Yukio Nakamura, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2017</study_first_submitted>
  <study_first_submitted_qc>October 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2017</study_first_posted>
  <last_update_submitted>October 16, 2017</last_update_submitted>
  <last_update_submitted_qc>October 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shinshu University</investigator_affiliation>
    <investigator_full_name>Yukio Nakamura</investigator_full_name>
    <investigator_title>Lecturer at Shinshu University School of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Proton Pump Inhibitors</mesh_term>
    <mesh_term>Esomeprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

